leadf
logo-loader
viewCo-Diagnostics

Full interview: Co-Diagnostics begins selling newest product that detects the eastern equine encephalitis virus

Co-Diagnostics, Inc. (NASDAQ:CODX) CEO Dwight Egan tells Proactive the Salt Lake City, Utah-based company will begin selling its new diagnostic test called the Vector Smart NAM-e multiplex test, which detects the eastern equine encephalitis virus (EEE), with West Nile virus, and St. Louis encephalitis. Egan says EEE is a mosquito-borne disease that kills half of those who are infected. The company is selling the diagnostic to counties within the US that would use it to test mosquito populations.

Quick facts: Co-Diagnostics

Price: 14.82 USD

NASDAQ:CODX
Market: NASDAQ
Market Cap: $416.19 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Co-Diagnostics named herein, including the promotion by the Company of Co-Diagnostics in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Co-Diagnostics to reach wider audience with FDA Emergency Use Authorization...

Co-Diagnostics Inc (NASDAQ:CODX) CEO Dwight Egan tells Proactive the molecular diagnostics company's Logix Smart coronavirus test has obtained Emergency Use Authorization from the FDA to be used to diagnose SARS-CoV-2. Egan says the authorization confirms the quality and performance of the...

on 04/07/2020

2 min read